Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 26.02 BRL 2.56% Market Closed
Market Cap: 44.6B BRL
Have any thoughts about
Raia Drogasil SA?
Write Note

Gross Margin
Raia Drogasil SA

29.8%
Current
30%
Average
32.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.8%
=
Gross Profit
11.2B
/
Revenue
37.7B

Gross Margin Across Competitors

Country BR
Market Cap 44.6B BRL
Gross Margin
30%
Country ZA
Market Cap 98.2B Zac
Gross Margin
23%
Country ZA
Market Cap 31.9B Zac
Gross Margin
23%
Country US
Market Cap 7.5B USD
Gross Margin
18%
Country JP
Market Cap 845.2B JPY
Gross Margin
35%
Country SA
Market Cap 16.8B SAR
Gross Margin
39%
Country CN
Market Cap 27.3B CNY
Gross Margin
38%
Country MX
Market Cap 70.6B MXN
Gross Margin
23%
Country JP
Market Cap 547.7B JPY
Gross Margin
20%
Country NL
Market Cap 2.9B EUR
Gross Margin
23%
Country JP
Market Cap 457.5B JPY
Gross Margin
31%
No Stocks Found

Raia Drogasil SA
Glance View

Market Cap
44.6B BRL
Industry
Retail

Raia Drogasil SA is a leading retail pharmacy chain in Brazil, established through the merger of two prominent companies, Raia and Drogasil, creating a powerhouse in the pharmaceutical and personal care sectors. With a mission to cater to the healthcare and wellness needs of Brazilians, the company operates over 2,300 stores across key urban regions, boasting a comprehensive product range that includes prescription medications, over-the-counter drugs, beauty products, and health-related services. Investors are drawn to Raia Drogasil for its strong market position, supported by a consistent strategy of expansion, innovation, and a commitment to customer service, making it a trusted name in the fast-growing Brazilian pharmaceutical market. In recent years, Raia Drogasil has implemented advanced sales and inventory management systems to enhance operational efficiency and customer satisfaction. The company's focus on growth is further reinforced by a robust online presence, enabling it to capture emerging e-commerce trends among Brazilian consumers. With a resilient business model, anchored by a broad geographic footprint and an increasingly diverse product offering, Raia Drogasil stands poised for long-term success. As Brazil's middle class continues to expand and healthcare spending rises, the company presents a compelling opportunity for investors looking to tap into a thriving market with promising growth potential.

RADL3 Intrinsic Value
20.8 BRL
Overvaluation 20%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
29.8%
=
Gross Profit
11.2B
/
Revenue
37.7B
What is the Gross Margin of Raia Drogasil SA?

Based on Raia Drogasil SA's most recent financial statements, the company has Gross Margin of 29.8%.